Borderline Personality Disorder (BPD)

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Seed Therapeutics
Seed TherapeuticsNY - New York
1 program
routine psychotherapy for Borderline Personality DisorderN/A1 trial
Active Trials
NCT04095546WithdrawnEst. Dec 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
Seed Therapeuticsroutine psychotherapy for Borderline Personality Disorder

Clinical Trials (1)

NCT04095546Seed Therapeuticsroutine psychotherapy for Borderline Personality Disorder

Epigenetic Changes in Psychotherapy of Adolescents With Borderline Personality Pathology

Start: Apr 2022Est. completion: Dec 2024
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space